http://www.investorideas.com/news/2016/biotech/02171.asp
about 3/4 down the page
"
TLSR : Is there a timeline for approvals, including in the U.S. market?
MW : The expectation is that OncoSil will get an approval in the EU in the next few weeks, which could pull the trigger. Once it has the CE mark for the European markets, that would allow commercialization and sales in the EU. Then the company intends to go into the U.S. market. It is expected to file for an investigational device exemption (IDE) with the FDA in Q4/16."
gltah
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |